Overexpressed Receptors and Proteins in Lung Cancer
作者： Bapi Gorain , Subrat Kumar Bhattamishra , Hira Choudhury , Utpal Nandi , Manisha Pandey
DOI: 10.1016/B978-0-12-815720-6.00003-4
关键词: Cancer cell 、 Cancer Microenvironment 、 Tumor progression 、 Lung cancer 、 Function (biology) 、 Stages of growth 、 Medicine 、 Cancer prevention 、 Cancer research 、 Receptor
摘要: Abstract The worldwide prevalence of lung cancer is amongst the greatest all cancers, and deaths due to are highest. Current researches focusing on a molecular understanding microenvironment obtain maximal efficacy projected chemotherapeutic formulations. Overexpressed receptors frequently observed in cells assemble nutrients provide needs for uncontrolled growth. In this chapter, we discuss generally overexpressed cells. Each receptor plays an important function at different stages growth tumor progression. Therefore, discussion will be value researchers who aim link expression these optimize develop target-specific delivery chemotherapeutics order future prospects prevention with superior decreased systemic toxicities.
sci-hub.se 参考文章(197)
Namrata Soni, Neetu Soni, Himanshu Pandey, Rahul Maheshwari, Prashant Kesharwani, Rakesh Kumar Tekade, Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles. joint international conference on information sciences. ,vol. 481, pp. 107- 116 ,(2016) , 10.1016/J.JCIS.2016.07.020
Martin C. S. Wong, Xiang Qian Lao, Kin-Fai Ho, William B. Goggins, Shelly L. A. Tse, Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Scientific Reports. ,vol. 7, pp. 14300- ,(2017) , 10.1038/S41598-017-14513-7
Rajneet Kaur Khurana, Ashay Jain, Atul Jain, Teenu Sharma, Bhupinder Singh, Prashant Kesharwani, Administration of antioxidants in cancer: debate of the decade Drug Discovery Today. ,vol. 23, pp. 763- 770 ,(2018) , 10.1016/J.DRUDIS.2018.01.021
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal, Cancer statistics, 2016 CA: A Cancer Journal for Clinicians. ,vol. 66, pp. 7- 30 ,(2016) , 10.3322/CAAC.21332
Kristen L. Pierce, Richard T. Premont, Robert J. Lefkowitz, Seven-transmembrane receptors. Nature Reviews Molecular Cell Biology. ,vol. 3, pp. 639- 650 ,(2002) , 10.1038/NRM908
Roderick J. Phillips, Marie D. Burdick, Marin Lutz, John A. Belperio, Michael P. Keane, Robert M. Strieter, The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. American Journal of Respiratory and Critical Care Medicine. ,vol. 167, pp. 1676- 1686 ,(2003) , 10.1164/RCCM.200301-071OC
Michael Majores, Anne Schindler, Angela Fuchs, Johannes Stein, Lukas Heukamp, Peter Altevogt, Glen Kristiansen, Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients. BMC Clinical Pathology. ,vol. 15, pp. 19- 19 ,(2015) , 10.1186/S12907-015-0019-Z
M D Castellone, M O Laukkanen, H Teramoto, R Bellelli, G Alì, G Fontanini, M Santoro, J S Gutkind, Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma Oncogene. ,vol. 34, pp. 1679- 1687 ,(2015) , 10.1038/ONC.2014.104
Anne M Schultheis, Marc Bos, Katja Schmitz, Lea Wilsberg, Elke Binot, Jürgen Wolf, Reinhard Büttner, Hans-Ulrich Schildhaus, Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer Modern Pathology. ,vol. 27, pp. 214- 221 ,(2014) , 10.1038/MODPATHOL.2013.141
Beverly A. Teicher, Targets in small cell lung cancer Biochemical Pharmacology. ,vol. 87, pp. 211- 219 ,(2014) , 10.1016/J.BCP.2013.09.014